Member Login | Committee Login | Forgotten Password | Contact Us

  Home | Meetings | Position Papers | Research and Audit | Education | ABCD Audits on N3 | ABCD Journal (BJD)

Association of British Clinical Diabetologists

ABCD Endobarrier Studies - REVISE-Diabesity

Quick Launch  
 
Endobarrier Study
 
What is Endobarrier?
 
Effectiveness of Endobarrier - previous trials
 
What is the REVISE-Diabesity study?
 
Facts and Figures about REVISE-Diabesity set-up
 
Progress of the REVISE-Diabesity study
 
Advice for clinicians who might have patients for the study
 
Advice for Patients who might be interested in taking part in the study
 
Press
 
Contact the research team
 
Acknowledgements
 
Research staff login
 
Search Documents
SearchGo
 

As of April 2016 the REVISE-Diabesity Study HAS COMPLETED ONE YEAR and has one more year to run.
This study is a multi-centre randomised controlled trial evaluating the effectiveness of a new device called Endobarrier combined with a GLP-1 receptor analogue (liraglutide) or used alone.
REVISE-Diabesity is funded by ABCD is supported by the NHS, as one of the National Institute for Health Research’ (NIHR) Clinical (Diabetes) Research Network Portfolio Studies. The presentation of the one year results triggered a BBC news item which is available to view. A presentation of the 1-year results, including assessment of 10-year cardiovascular risk, can be viewed  in a webcast from the ADA meeting in New Orleans on 12 June 2016. The presentation included pictures of typical patients treated with Endobarrier to show what happened to them, and also MRI scans demonstrating the considerable reduction in amount of fat in the liver and pancreas caused by the weight loss. There was also a discussion of the rare hepatic abscess complication.

   
Endobarrier  
What is endobarrier? Introduction to endobarrier
Effectiveness of endobarrier - previous trials Clinical data on the effectiveness of endobarrier
   
REVISE-Diabesity  
What is REVISE-Diabesity study? A brief summary of ABCD's endobarrier study
Facts and Figures about REVISE-Diabesity set-up Some facts and figures about ABCD's endobarrier study
Progress of the REVISE study Where are we now with ABCD's endobarrier study
   
Joining the Study  
Advice for clinicians who might have patients for the study Do you have patients who might benefit from endobarrier and might want to take part in the trial?
Advice for Patients who might be interested in taking part in the study Are you a patient who might benefit from endobarrier and might want to take part in the trial?
   
Press  
On-line reports of the study Just a sample of the response of the media to the launch of the study
   
Contact  
Contact the research team Details of the teams at the different ABCD endobarrier study sites
   
Acknowledgements  
Acknowledgements Acknowledgements for the study
   
Login  
Research staff login Entrance to the secure REVISE-Diabesity subweb for staff running the study
 

Working to support high quality diabetes care in the UK

 
Links